【発明の名称】器質性精神障害の治療に活性な制御放出形態の製薬組成物の調製に於ける、5―メチルテトラヒドロ葉酸、5―ホルミルテトラヒドロ葉酸及びそれらの製薬的に許容し得る塩の使用並びに関連する製薬組成物

Title:

Document Type and Number:

Japanese Patent JPH0791190

Kind Code:

B2

Abstract:

This invention relates to the use of 5-methyltetrahydrofolic acid, 5-formyltetrahydrofolic acid and their pharmaceutically acceptable salts in the preparation of pharmaceutical compositions in controlled-release form which are active in the therapy of organic mental disturbances and in particular in the treatment of senile and presenile primary degenerative dementia of Alzheimer type and multiinfarctual dementia, and to the pharmaceutical compositions concerned.

More Like This:

WO/2011/072861	SUPPOSITORY COMPRISING PANTOPRAZOLE
JPH07277983	PROSTAGLANDIN E1-RELATED COMPOUND-CONTAINING SUPPOSITORY AND MEDICINAL USE THEREOF

Inventors:

Christina Les Graziers

Application Number:

JP7315690A

Publication Date:

October 04, 1995

Filing Date:

March 22, 1990

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Bioresearch SPA

International Classes:

A61K9/02; A61K9/08; A61K9/22; A61K31/505; A61K31/519; A61P25/28; C07D475/04; C07C233/81; (IPC1-7): A61K31/505

Attorney, Agent or Firm:

Yohei Yamashita (1 person outside)

Next Patent: PRESTRESSED SEGMENT RING